DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Mascarenhas J, Mughal TI, Verstovsek S.
Biology and clinical management of myeloproliferative neoplasms and development of the JAK inhibitor ruxolitinib.
Curr Med Chem 2012;
19: 4399-413
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.